3 Biotech companies that will lead the way strong into 2020 with trials and or about to start already with great success and still so CHEAP and decent money to be made.
PAA - Early success with trials already with more results due end of the year with the aim to begin human trials off the back of K9 cancer trial success. CHEAP and decent money to be made.
ANP - UK presentation next week, discussions around European medical approval, trials results soon, IP protected, No other effective treatment out there. Massive media coverage in Fin Review. CHEAP.
IHL - Trials starting soon with results Q1 2020 Worthy of a bounce off the recent lows. Decent money to be made and still CHEAP.
